The World Health Organisation (WHO) has prequalified the first diagnostic test for glucose-6-phosphate dehydrogenase (G6PD) deficiency, a critical tool for safely administering WHO-recommended treatments to prevent relapse of Plasmodium vivax (P. vivax) malaria.
Trending
- FGM prevalence in Ebonyi drops to 20.4%
- LASEMA restores normalcy after Kara bridge truck accident
- NOA strengthens ties with NOSDRA for environmental awareness in Kwara
- LASTMA rescues 3 in multi vehicle crash on LASU-Isheri road
- Sebastian joins SDP for 2027 Benue governorship race
- Gov Aliyu flags off 2026 seasonal malaria prevention campaign
- MSF warns of worsening cholera outbreak in Borno
- FAAN launches waste segregation, recycling programme at Lagos airport
